The estimated Net Worth of John H Jr Kehl is at least $9.05 Milhão dollars as of 1 May 2013. John Kehl owns over 12,500 units of Edwards Lifesciences Corp stock worth over $7,871,887 and over the last 21 years John sold EW stock worth over $1,181,096.
John has made over 17 trades of the Edwards Lifesciences Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently John exercised 12,500 units of EW stock worth $274,500 on 1 May 2013.
The largest trade John's ever made was selling 29,800 units of Edwards Lifesciences Corp stock on 17 March 2004 worth over $942,574. On average, John trades about 5,150 units every 71 days since 2004. As of 1 May 2013 John still owns at least 115,339 units of Edwards Lifesciences Corp stock.
You can see the complete history of John Kehl stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE, CA, 92614.
Over the last 21 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo, eSteven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: